151 related articles for article (PubMed ID: 33128474)
21. Secondary Angiosarcoma With C-MYC Amplification Following Prophylactic Bilateral Mastectomy and Autologous Breast Reconstruction: Report of a Case and Review of the Literature.
Webb C; Partain N; Koduru P; Hwang H; Sarode VR
Int J Surg Pathol; 2021 Apr; 29(2):205-210. PubMed ID: 32552130
[TBL] [Abstract][Full Text] [Related]
22. Detection of Gene Amplification by Multiplex Ligation-Dependent Probe Amplification in Comparison with In Situ Hybridization and Immunohistochemistry.
Tabarestani S; Ghaderian SM; Rezvani H
Asian Pac J Cancer Prev; 2015; 16(17):7997-8002. PubMed ID: 26625832
[TBL] [Abstract][Full Text] [Related]
23. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
[TBL] [Abstract][Full Text] [Related]
24. Reduced H3K27me3 expression in radiation-associated angiosarcoma of the breast.
Mentzel T; Kiss K
Virchows Arch; 2018 Mar; 472(3):361-368. PubMed ID: 28983701
[TBL] [Abstract][Full Text] [Related]
25. Radiation-induced vascular lesions of the skin: an overview.
Flucke U; Requena L; Mentzel T
Adv Anat Pathol; 2013 Nov; 20(6):407-15. PubMed ID: 24113311
[TBL] [Abstract][Full Text] [Related]
26. Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.
Blancato J; Singh B; Liu A; Liao DJ; Dickson RB
Br J Cancer; 2004 Apr; 90(8):1612-9. PubMed ID: 15083194
[TBL] [Abstract][Full Text] [Related]
27. The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification.
Italiano A; Thomas R; Breen M; Zhang L; Crago AM; Singer S; Khanin R; Maki RG; Mihailovic A; Hafner M; Tuschl T; Antonescu CR
Genes Chromosomes Cancer; 2012 Jun; 51(6):569-78. PubMed ID: 22383169
[TBL] [Abstract][Full Text] [Related]
28. Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?
Sauer T; Wiedswang G; Boudjema G; Christensen H; Karesen R
APMIS; 2003 Mar; 111(3):444-50. PubMed ID: 12752225
[TBL] [Abstract][Full Text] [Related]
29. C-MYC positive angiosarcoma of skin and breast following MammoSite® treatment.
Tidwell WJ; Haq J; Kozlowski KF; Googe PB
Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632799
[TBL] [Abstract][Full Text] [Related]
30. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases.
Brenn T; Fletcher CD
Am J Surg Pathol; 2005 Aug; 29(8):983-96. PubMed ID: 16006792
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
Persons DL; Borelli KA; Hsu PH
Mod Pathol; 1997 Jul; 10(7):720-7. PubMed ID: 9237184
[TBL] [Abstract][Full Text] [Related]
32. Primary and secondary cutaneous angiosarcoma: Distinctive clinical, pathological and molecular features.
Ronchi A; Cozzolino I; Zito Marino F; De Chiara A; Argenziano G; Moscarella E; Pagliuca F; Franco R
Ann Diagn Pathol; 2020 Oct; 48():151597. PubMed ID: 32829071
[TBL] [Abstract][Full Text] [Related]
33. The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer.
Pan W; Wang W; Huang J; Lu K; Huang S; Jiang D; Bu D; Liu J; Jing H; Yao J; Hou Y
Jpn J Clin Oncol; 2020 Apr; 50(4):446-455. PubMed ID: 32297641
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous Angiosarcoma: Clinical and Pathology Study of 16 Cases.
Requena C; Sendra E; Llombart B; Sanmartín O; Guillén C; Lavernia J; Traves V; Cruz J
Actas Dermosifiliogr; 2017 Jun; 108(5):457-465. PubMed ID: 28318524
[TBL] [Abstract][Full Text] [Related]
35. c-myc and cutaneous vascular neoplasms.
Feller JK; Mahalingam M
Am J Dermatopathol; 2013 May; 35(3):364-9. PubMed ID: 23221487
[TBL] [Abstract][Full Text] [Related]
36. Violaceous plaques and breast tenderness in a 71-year-old breast cancer survivor. Cutaneous radiation-associated angiosarcoma of the breast.
Yagerman S; Pulitzer M; Spencer P; Marghoob A
JAMA Dermatol; 2013 Aug; 149(8):973-4. PubMed ID: 23783530
[No Abstract] [Full Text] [Related]
37. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array.
Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ
Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174
[TBL] [Abstract][Full Text] [Related]
38. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
Wang XJ; Medeiros LJ; Lin P; Yin CC; Hu S; Thompson MA; Li S
Am J Surg Pathol; 2015 Sep; 39(9):1250-8. PubMed ID: 25828389
[TBL] [Abstract][Full Text] [Related]
39. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers.
Wang M; Liang L; Lei X; Multani A; Meric-Bernstam F; Tripathy D; Wu Y; Chen H; Zhang H
Ann Diagn Pathol; 2018 Aug; 35():69-76. PubMed ID: 29843069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
